Conagra Brands Inc.: Form 10-Q for the period ended Feb 23, 2025
Filed with the SEC on Apr 3, 2025 and accepted by EDGAR at Apr 3, 2025, 20:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-02-23. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-11-25 to 2025-02-23 | $2.84bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-05-27 to 2025-02-23 | $8.83bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-11-25 to 2025-02-23 | $2.13bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-05-27 to 2025-02-23 | $6.53bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2024-11-25 to 2025-02-23 | $443.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-05-27 to 2025-02-23 | $1.20bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-11-25 to 2025-02-23 | $395.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-05-27 to 2025-02-23 | $1.36bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-11-25 to 2025-02-23 | $43.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-05-27 to 2025-02-23 | −$33.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-11-25 to 2025-02-23 | $145.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-05-27 to 2025-02-23 | $896.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-11-25 to 2025-02-23 | $0.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-05-27 to 2025-02-23 | $1.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-11-25 to 2025-02-23 | $0.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-05-27 to 2025-02-23 | $1.87 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-11-25 to 2025-02-23 | 479,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-05-27 to 2025-02-23 | 479,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-05-27 to 2025-02-23 | $1.35bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-05-27 to 2025-02-23 | $304.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2024-05-27 to 2025-02-23 | $502.2m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2024-05-27 to 2025-02-23 | $64.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-02-23 | $49.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-02-23 | $2.97bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-02-23 | $20.74bn | us-gaap:Assets |
| Current liabilities | At period end2025-02-23 | $4.30bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-02-23 | $11.97bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-02-23 | $7.27bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2025-02-23 | $877.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-02-23 | $8.78bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-02-23 | 477,362,470 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-25-004399. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.